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Abstract 
Dietary nitrate supplementation via beetroot juice (BR) has been shown to have positive 
effects on mitochondrial and muscle efficiency during large muscle mass exercise in humans, 
and more recently on locomotory muscle blood flow (Q̇) in rats. To date, an integrated measure 
of these effects has not been performed in humans. Therefore, we assessed the influence of BR 
on Q̇ and muscle oxygenation characteristics during moderate and severe intensity handgrip 
exercise. Seven healthy men (age: 25 ± 3 yrs; height: 179 ± 4 cm; weight: 82 ± 9 kg) completed 
four constant-power exercise tests randomly assigned to condition (BR or placebo (PL)) and 
intensity (moderate (40% peak) or severe (85% peak)). Resting mean arterial pressure was 
significantly lower after BR compared to PL (79.3 ± 5.8 vs 86.8 ± 6.7 mmHg; p < 0.01). All 
subjects were able to sustain 10 min of exercise at moderate intensity in both conditions. BR had 
no significant effect on exercise tolerance during severe (342 ± 83 vs 382 ± 138 s, p = 0.382). 
Brachial artery Q̇ was not significantly different after BR at rest or any time during exercise in 
either intensity. Deoxygenated-[hemoglobin + myoglobin] was elevated at min 2 & 3 for 
moderate (p < 0.05) and throughout severe exercise (p = 0.03) after BR. The estimated metabolic 
cost (V̇O2) was not significantly different during either intensity after BR. These findings support 
the notion that an acute dose of BR may be valuable to reduce blood pressure in young adults, 
but revealed that it does not augment Q̇ or V̇O2 during small muscle mass handgrip exercise. 
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Chapter 1 - Introduction 
Dietary nitrate supplementation (including beetroot juice (BR)) is well documented to 
have positive effects during large muscle mass exercise in man (7, 61, 72, 100, 105). These 
effects include lowering the O2 cost, or oxygen consumption (V̇O2) (7, 72) and/or reducing the 
ATP cost of work (5, 39) during submaximal exercise, which may translate to the enhanced 
exercise tolerance found during severe intensity exercise. The precise mechanism(s) for these 
effects still remains uncertain, but they are facilitated through the reduction of the dietary nitrate 
(NO3
-
) to nitrite (NO2
-
) in the mouth (75). Once absorbed into the circulatory system, NO2
- 
is 
readily converted to nitric oxide (NO) in hypoxic (27, 95) and acidic (77) environments, which 
may be present at the exercising muscle. 
 A fundamental role of NO is that of a potent vasodilator (32, 35, 89); as such it has been 
demonstrated that BR supplementation augments blood flow (Q̇) to the working muscle. This 
was first experimentally investigated in rats during submaximal treadmill running (37). These 
authors found that BR supplementation resulted in an increased Q̇ to the hindlimb, despite a 
lower exercising mean arterial pressure (MAP). These findings demonstrate that BR may change 
the regulation of Q̇ relative to V̇O2, as V̇O2 and Q̇ generally increase in proportion to one another 
across a range of exercise intensities (1, 84). In a follow up study, Ferguson and colleagues (36) 
repeated the previous experiment using both a low (0.3 mmol·kg
-1
·day
-1
) and high (1 mmol·kg
-
1
·day
-1
) dose of BR and found no difference in Q̇ or microvascular partial pressure of O2 (PmvO2) 
with the low dose. Importantly, the high dose yielded similar findings to the original study with 
an increased Q̇, while further providing evidence of increased PmvO2, supporting that BR 
increased Q̇ relative to V̇O2. Recently the effect on Q̇ was investigated in human subjects (19, 
62), but no change in brachial artery blood flow (Q̇BA) was found in healthy, young men and 
2 
women during moderate intensity handgrip exercise, consistent with the findings of low dose BR 
in rats. 
These data in humans may provide valuable insights into the efficacy of BR as a therapy 
for patient populations, because handgrip exercise (with duty-cycles ≥ 50%) provides an 
opportunity to measure the effects of BR in an exercise model in which the O2 delivery is 
inadequate to support the V̇O2 requirements due to mechanical impediments to Q̇ (15, 99). This 
condition of reduced O2 delivery is experienced in several patient populations (e.g., chronic heart 
failure (CHF), chronic obstructive pulmonary disease (COPD), and diabetes). Additionally, 
handgrip exercise may prove useful for investigation of these patient populations directly 
because of the reduced dependence on central cardiorespiratory adjustments, specifically of 
cardiac output. 
Importantly, previous studies in humans using BR provided no measure of V̇O2, PmvO2, 
or fractional O2 extraction (which can be estimated noninvasively via deoxygenated-[hemoglobin 
+ myoglobin] (deoxy-[Hb + Mb]) and used to estimate V̇O2) (15, 29, 31, 66). Moreover, when 
measurements were made, it was after fixed durations of moderate intensity submaximal work, 
leaving the effects of BR on exercise tolerance and the resulting end-exercise variables unknown. 
These latter findings carry important implications for patient populations, such as CHF, as 
accumulating evidence suggests BR may be effective for enhancing quality of life through 
improvements in exercise and/or daily activity tolerance (106).  
Therefore, the purpose of this investigation was to resolve whether or not BR 
supplementation provided beneficial effects in small muscle mass exercise at both moderate and 
severe exercise intensities. Specifically, we tested the hypotheses that with BR supplementation, 
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1) Q̇BA would not be significantly different during exercise; 2) V̇O2 would be lower during 
exercise; and 3) tolerance of exercise (Tlim) would be increased during severe intensity exercise. 
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Chapter 2 - Review of Literature 
 Theory of measurements 
 Doppler ultrasound 
 Doppler ultrasound is a powerful tool to noninvasively and precisely measure vascular 
hemodynamics across a variety of vessels, exercise modes, exercise intensities, and importantly 
across the crucial rest-to-exercise transition. Instantaneously and continuously measuring Q̇ for 
kinetic analysis and without stopping exercise was a significant advance of methodology for 
exercise physiologists over the previous standard, venous occlusion plethysmography. The value 
for Q̇ is calculated using the variables directly measured by the ultrasound, vessel radius (r) and 
mean blood velocity (Vmean) in the formula: Q̇ = π r
2 
Vmean. The measurement of r is taken in B-
mode, or 2D mode, which utilizes the transducers of the ultrasound probe to scan a plane through 
the interrogated tissue. This mode allows for accurate measurement of vessel diameters, which 
are subsequently converted to r by dividing the diameter in half.  
 The measurement of Vmean is taken in pulsed wave Doppler mode. This mode takes 
advantage of the Doppler Effect and the interaction between the emitted sound waves and red 
blood cells (RBCs). Briefly, the frequency of the waves will be altered based on the direction of 
travel and velocity of the RBCs. If the RBCs are moving toward the probe, the frequency will 
increase with further rise compounded by their velocity. If the RBCs are moving away from the 
probe, the frequency will decrease and this drop will be further exacerbated by their velocity. 
This allows real time measure of the pulsatile nature of Q̇ and gives researchers the ability to 
distinguish between antegrade and retrograde flow. The strength of these signals are maximized 
by controlling the angle of insonation (< 60°) as the above phenomenon requires movement 
toward or away from the probe. 
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 Near infrared spectroscopy 
 Near infrared spectroscopy (NIRS) provides a measure of microvascular oxygenation 
characteristics with great accuracy and temporal resolution. This is accomplished by 
interrogating the tissue of interest with light composed of visible and near infrared (NIR) 
wavelengths and measuring the light that is able to traverse the tissue. The range of viable 
wavelengths has been defined at the upper limit of approximately 1000 nm due to the overriding 
absorption by water and at the lower limit of about 650 nm due to the vast absorption by 
hemoglobin (Hb). Many substances present in human tissue have well documented absorption 
spectra at NIR wavelengths and importantly have variable concentrations during exercise, of 
note to this investigation are oxygenated hemoglobin and myoglobin (Mb) (oxy-[Hb + Mb]), 
deoxygenated hemoglobin and myoglobin (deoxy-[Hb + Mb]), and the summation of these 
variables in total hemoglobin and myoglobin (total-[Hb + Mb]). The presence of oxygen alters 
these absorption characteristics and allows the technique to estimate the oxygenation 
characteristics of the tissue. Sampling at a rate of 50 Hz, the OxiplexTS (ISS, Champaign, IL, 
USA) used in the current study, allows for accurate kinetic analysis of NIRS signals. 
 The NIRS technique is not without limitations as it must deal with unresolved questions 
regarding the effect of adipose tissue thickness (ATT) on the signals, the contribution of Mb 
during exercise, and the effect of scattering within the tissue (38). Scientist have become aware 
of the negative effects of ATT on NIRS signal strength and some have proposed corrective 
formulas (12), but there are still questions concerning the anatomical and physiological make-up 
of the tissues underlying the NIRS probe. The deleterious effects of ATT have been addressed in 
the current study by selecting handgrip exercise and observing the oxygenation status of the 
flexor digitorum superficialis (FDS), which regularly has a low ATT compared to sites in the 
legs and allows for complete description of the active muscle.  
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While NIRS is unable to differentiate the contribution of Hb from Mb to oxygenation 
characteristics, studies have made effort to reveal their influence on deoxy-[Hb + Mb] and total-
[Hb + Mb]. These studies suggest that while Mb may contribute 80% of the NIRS signal, it does 
restrict the interpretation of NIRS measurements. The time-course change of deoxy-[Hb + Mb] is 
similar to that of the microvascular partial pressure of oxygen (PmVO2) and remains a viable tool 
to index local O2 extraction (66, 96). The increase in total-[Hb + Mb] with exercise can be used 
as an indication of microvascular hematocrit (28) because the volume of Mb remains unchanged 
and appears to match the increase of microvascular hematocrit of in vivo models (65). 
Scattering of photons is a limitation of the NIRS measurement if the equipment used does 
not account for this effect. Briefly, scatter is the chaotic deflection of light particles as they pass 
through and interact with substances in the environment. An increase in scatter results in an 
increase in the path length of the photons, leading to artificial increases in the absorption of the 
photons. The largest source of scatter in this study is the melanin of the skin and to a lesser 
extent bone tissue. The NIRS system used in the current study corrects for this scatter by use of a 
frequency-domain multi-distance technique that alters the frequency and intensity of the emitted 
light as well as the distance between the emitters and sensors to develop a real-time scattering 
coefficient (μs
’
). This coefficient allows correction of the scattering and absolute quantification 
of the measured variables in micro-molar (μM) concentration. 
 Non-invasive blood pressure 
 The non-invasive blood pressure (NIBP) measurement used in the current investigation 
makes use of the oscillometric measuring principle. To accomplish this, the cuff is inflated to a 
pressure that exceeds systolic blood pressure (SBP) and is slowly released while measuring the 
pressures associated with oscillations in the cuff produced by the pulsating artery. The first and 
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last oscillations will approximate the Korotkoff sounds that designate the SBP and diastolic 
blood pressure (DBP), respectively. Using these values the mean arterial pressure (MAP) can be 
calculated as 1/3 (SBP – DBP) + DBP. The two-handed ergometer used in the current 
investigation precluded the use of the brachial artery and necessitated the use of the posterior 
tibial artery. To account for the increased hydrostatic pressure in the ankle while seated, a 
correction factor was used based on the distance between the heart and ankle which equated to 
subtracting 76 mmHg per meter difference (42). Pilot work in our laboratory validated the 
correction factor with measurements taken from the ankle and arm at heart level while the 
subjects were seated at the ergometer. 
 Exercise: Stress, parameters, and kinetics 
The majority of physiological systems in humans have evolved with the function to 
maintain homeostasis in the face of a wide array of stressors. Exercise is a common, highly 
taxing stress imposed on the body that requires the systems to sustain energy supply and ATP 
concentration (14), regulate acid-base balance (54), and regulate core body temperature (86). 
Commensurate with the first contraction, ATP demand increases instantaneously and is supplied 
by the immediate and anaerobic energy pathways. These pathways are limited in capacity and 
thus the ATP must be supplied by alternative pathways as exercise continues, specifically 
oxidative phosphorylation. Oxygen uptake (V̇O2) measured at the mouth is a vital tool for the 
interpretation of whole body and synergistic muscle group performance during exercise as it has 
been shown to represent oxygen uptake at the muscle (V̇O2m) (9). 
Central to the understanding of V̇O2 is the Fick principle, which describes V̇O2 as the 
product of cardiac output (CO) and the arteriovenous difference (a-v̄O2). As exercise continues 
or increases in intensity, the parameters of the Fick principle adjust accordingly to match the 
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metabolic demands. Any given increase in V̇O2 will be the result of an increase in CO, increase 
in a-v̄O2, or a combination of the two. The increase in CO is accomplished via central regulation 
with increases in heart rate (HR), stroke volume (SV), or a combination of both. The increase in 
a-v̄O2 is accomplished via a maintained arterial O2 content (in most instances) and a decrease in 
venous O2 content, indicative of an increased O2 extraction by the active muscle. Small 
adjustments to the parameters allow characterization of V̇O2m as the product of blood flow (Q̇) 
and a-v̄O2. These muscle parameters are regulated in the same fashion as whole body V̇O2, with 
the further emphasis of resistance (R) or vascular conductance (VC) influencing Q̇, which will be 
described in further detail below in the control of blood flow section. 
Intensities below critical power (CP) (57) allow variables including V̇O2, Q̇, lactate ([La
-
]), pH, and phosphocreatine (PCr) to reach steady-state values before precipitous increase or 
decrease to levels that induce failure (58, 83). Exercise performed at intensities below CP will 
result in kinetic responses to steady-state lasting from seconds to minutes depending on the 
variable measured (45), the intensity of exercise (56), and the training status of the individual 
(10). Investigation of these variables in exercising forearms (53) revealed similar kinetic 
responses as Grassi et al. (45) found in lower body exercise. 
 Heterogeneity of Q̇ during active hyperemia 
 During the transition from rest to maximal intensity exercise CO increases 5- to 6-fold 
that of resting values.  This augmented Q̇ during exercise, or active hyperemia, is not evenly 
distributed within the body. Areas of high demand (the active, exercising muscle) receive a 
substantial proportion of the CO (approximately 75-85%), increasing Q̇ up to 100-fold that of 
resting values in individual areas and muscles. Even within the exercising muscle there exists 
important heterogeneity between the recruited regions and different muscle fiber types (68). By 
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prioritizing the distribution of Q̇ to actively working muscle, the body ensures adequate O2 
delivery and the ability to sustain the effort (48, 49). Acknowledging this understanding, when 
the system is observed as whole body or limb exercise, the heterogeneity appears homogenous 
with Q̇ and V̇O2 expressing a linear relationship from rest through increasing exercise intensity 
(1, 41, 84). Therefore, the next sections will describe the main factors influencing the control of 
Q̇ at the onset of contraction and during continuous exercise with a universal view of the system. 
At the onset of exercise Q̇ shows a biphasic increase with an initial rapid portion that plateaus at 
approximately 10 seconds (phase 1) and a second increase that begins around 20 seconds and 
progresses to the steady-state or maximal value at a slower rate lasting up to 2 minutes (phase 2). 
 Rapid increase of Q̇ at onset of exercise 
 Q̇ is defined using a variation of Ohm’s law, stating Q̇ is equal to the pressure gradient 
across a segment (ΔP) multiplied by VC. As a liquid, blood conforms to the laws of physics and 
will flow from an area of high pressure to one of low pressure. These areas are typically 
measured as the arterial (Pa) and venous (Pv) pressure on either side of a muscle bed. 
Mathematically VC is defined as the inverse of R (1/R) and in theory is the ease of flow through 
the vasculature. Therefore, Q̇ can be augmented by increasing ΔP, increasing VC, or a 
combination of the two.  
There are two prevailing hypotheses on the mechanism for phase 1 including the muscle 
pump and rapid vasodilation. The muscle pump theory suggests that with muscle contraction the 
increase in intramuscular pressure leads to compression of the veins consequently shunting the 
blood out and toward the heart. This venous emptying reduces Pv and increases the ΔP, thus 
augmenting Q̇ (8, 82). This mechanism is particularly valuable during upright exercise as 
standing posture increases the hydrostatic column on venous blood returning to the heart. It has 
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been suggested that the pumping action of the muscles contributes more than 30% of the energy 
needed to circulate blood in humans (92) and 60% in rats (73). The hydrostatic pressure appears 
to be required to elicit any increase of Q̇ as shown by the removal of an apparent muscle pump 
effect when the limb is elevated above heart level both in the leg (103) and the forearm (90, 98). 
Muscle contraction frequency is thought to have a more prominent effect on the muscle pump 
than the intensity of the contraction (73, 87), although contractions of sufficiently high intensity 
have been shown to impede Q̇ during exercise (76). The muscle pump is not without controversy 
as studies have shown no muscle pump effect on Q̇ when the vasculature is previously 
maximally dilated (47) or prevented from dilating during contractions (46).    
The rapid vasodilation theory suggests that Q̇ is increased at exercise onset due to a rapid 
increase in VC stimulated by mechanical factors, vasodilatory products of muscle contraction, or 
some combination of the two. These mechanical factors include myogenic response to vessel 
compression and lengthening. Muscle induced vessel deformation elicits endothelium-dependent 
and -independent dilation (25, 78) which may be crucial to the rapid Q̇ increase at exercise onset, 
both independently via the increased VC and in combination with the muscle pump as suggested 
by the two studies of Hamann et al., (46, 47). Clifford et al., (25) suggest this compression 
induced dilation, rather than the artificial muscle pump, may account for the increased Q̇ shown 
by Tschakovsky et al., (98) even in the presence of ideal muscle pump circumstances. These in 
vitro studies (25, 78) suggest a time-course of 5-7 s for the mechanically induced dilation, but 
when studied in the human forearm this dilation was found to occur rapidly within 1-2 cardiac 
cycles (64, 97). 
There are many vasodilatory substances that have been shown to impart effects during 
the onset of skeletal muscle contraction with varying time-courses and effectiveness. These 
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include adenosine and ATP (18, 34), potassium (K
+
) (33, 46), nitric oxide (NO) (18, 20), and 
prostaglandins (PG) (11, 79). Similar to the mechanically induced rapid vasodilation, the 
metabolically induced vasodilation has opposition because of an occasional delay that could 
negate the rapid augmentation of Q̇. A study that used direct application of vasodilators (104) has 
suggested a time delay of 5-12 s in animal vessels. While it is easy to discount this hypothesis 
based on this finding, it is important to consider the complexity of the system in which these 
vasodilatory substances exist and that a metabolic demand or change in oxygen pressure (PO2) is 
likely elemental to the dilatory process. This is emphasized by the largely attenuated Q̇ following 
a single contraction when K
+
 flow across a membrane is blocked or concentration is altered (2, 
46).  
 Rise of Q̇ to steady-state or peak 
The second phase of Q̇ augmentation is a matching phase during which Q̇ is regulated in 
an attempt to match the metabolic demand. This matching is critical to the health of cells as 
hyperoxic and hypoxic environments have been shown to increase the rate of reactive oxygen 
species (ROS) production (22).  Phase 2 has a slower rate of change relative to phase 1, but can 
see much greater absolute changes being influenced by the mass of the active muscle, exercise 
intensity, and environmental factors. Phase 2 is thought to be largely driven by the presence of 
vasoactive substances released locally consequential to metabolic increases and mechanical 
activation. Importantly, these vasodilators act to attenuate the local sympathetic vasoconstriction 
caused by the increased systemic sympathetic nerve activity which accompanies physical activity 
and exertion. There are many vasodilatory substances that have been shown to impart effects 
during skeletal muscle contraction with varying time-courses and efficacies including adenosine 
and ATP (18, 34), potassium (K
+
) (33), nitric oxide (NO) (11, 26), and prostaglandins (PG) (11, 
12 
79). The predominant determinant of this control remains controversial and is currently under 
heavy investigation, but a general consensus supports redundancy between the dilators. 
However, the vasodilator of interest to the present study is NO and will be discussed further 
below. 
 Sources of NO 
 Endogenous production 
 Skeletal muscles in all mammals contain enzymes whose function is to produce NO. 
Called nitric oxide synthases (NOS), these enzymes make use of L-arginine and oxygen to 
produce NO (81). There are three forms of NOS that have been identified, with the most 
abundant and active being neuronal NOS (nNOS) (91). The function of NOS is greatly 
attenuated when oxygen availability is reduced, which may explain the lower NOS function 
shown in CHF and advanced age. Once produced, if not utilized quickly, NO is rapidly 
scavenged by hemoglobin, myoglobin, and free radicals. This suggests NO is a powerful, but 
local signaling molecule. 
 Nitrite to NO 
 For many years, nitrite (NO2
-
) was considered an inactive ion. Recently, it was 
discovered that NO2
-
 is converted to NO when proper environmental conditions are present. This 
conversion occurs rapidly in hypoxic (27, 95) and acidic (77) conditions. Hemoglobin (26, 27, 
52) and myoglobin (52, 95), the primary O2 transporting molecules in mammals, facilitate this 
process. These considerations make the contracting muscle a prime location for this conversion 
to take place. It is possible that this pathway evolved to offset the reduced NO availability (via 
reduced NOS function) imparted by exercise. 
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 Nitrate – NO2
-
 – NO 
  Nitrate (NO3
-
) is present in substantial concentrations in many green leafy and root 
vegetables (e.g. spinach, arugula, lettuce, and beets) (74). Unfortunately, mammals lack the 
pathways to directly make use of this higher form of NO. Commensal anaerobic bacteria present 
in the oral cavity, however, maintain these functions. When NO3
-
 is consumed, some will be 
converted to NO2
-
 while in the mouth, but a majority will be swallowed and proceed to the 
stomach. Once in the digestive tract, NO3
-
 is readily absorbed into the blood stream and begins 
circulating the body. The salivary glands attract and concentrate the NO3
-
 allowing the bacteria 
sufficient time to facilitate the conversion to NO2
- 
(75). The discovery of this pathway introduced 
the possibility of dietary nitrate supplementation to be used as a therapeutic and ergogenic agent.  
 Actions of NO2
-
 in the body 
 The discovery of NO and its critical importance as a signaling molecule in the 
cardiovascular system led to the award of the 1998 Nobel Prize in physiology or medicine to 
Louis Ignarro, Ferid Murad, and Robert F. Furchgott. NO has many targeted areas of effect 
within the body and these have been reviewed in detail elsewhere (see (91)). The effects of 
particular interest to this study are NO’s actions as a potent vasodilator and modulator of 
metabolic efficiency. With NO2
-
 used to increase the opportunity for NO formation, many 
studies have investigated these vasodilatory and efficiency effects in vitro and in vivo.  
 One of the first studies to investigate the vasodilatory properties of NO2
-
 supplementation 
was performed by Modin and colleagues, (77). This study utilized isolated rat aortas exposed to 
physiological levels of NO2
-
 in both neutral and acidic pH conditions. The relaxation was 
augmented by the lower pH conditions and was correlated with the NO release. Two years later, 
Cosby et al., (26) investigated the effects of NO2
-
 in vivo with direct infusion into the brachial 
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arteries of human subjects at rest and during handgrip exercise. Q̇ was significantly elevated 
during both rest and during exercise, and this augmentation remained when NOS function was 
inhibited by L-NMMA.  
 In addition to the vasoactive properties of NO2
-
, accumulating evidence suggests that 
mitochondrial and muscle functions are impacted. The direct impact of NO on mitochondrial 
respiration has been observed since the early 1990s, and appears that NO inhibits the O2 binding 
sites of cytochrome c oxidase by directly competing with O2.  The net outcome of this 
competition is an enhanced efficiency resulting from reduced O2 consumption of the 
mitochondria and maintained ATP production (24). These findings have been further supported 
with the addition of NO2
-
 and deoxygenated myoglobin to the mitochondrial solution (88). These 
findings inspired the work of Larsen and colleagues (72), which tested the effects of a dietary 
NO3
-
 supplement on whole body O2 consumption during cycling exercise. This study was the 
first to reveal that a dietary supplement could reduce the V̇O2 associated with a given work rate 
in humans. Subsequent investigation by Larsen et al., (71) revealed this increase in 
mitochondrial efficiency was attributable to a reduced proton leak across the inner mitochondrial 
membrane. In 2012, Hernandez and colleagues (50) showed that dietary NO3
-
 supplementation 
increased fast-twitch muscle force production through effects on calcium handling and 
sensitivity.  
 Effects of beetroot supplementation 
 Control of Q̇ 
A huge burst of investigations utilizing beetroot (BR) supplementation has happened over 
the last decade. This “hot topic” of research was triggered by the work of Larsen and colleagues 
(72) paired with the high nitrate concentration found in BR (74). It has been demonstrated that 
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BR supplementation augments Q̇ to the working muscle. This was first experimentally 
investigated in rats during submaximal treadmill running (37). These authors found that BR 
supplementation resulted in an increased Q̇ to the hindlimb, despite a lower exercising mean 
arterial pressure (MAP). These findings conflict with the reduced V̇O2 shown with BR 
supplementation in other studies, as V̇O2 and Q̇ generally increase in proportion to one another 
across a range of exercise intensities (1, 84), and may reveal a dissociation of this relationship 
induced by BR. In a follow up study, Ferguson and colleagues (36) repeated the previous 
experiment using both a low (0.3 mmol·kg
-1
·day
-1
) and high (1 mmol·kg
-1
·day
-1
) dose of BR and 
found no difference in Q̇ or microvascular partial pressure of O2 (PmvO2) with the low dose. 
Importantly, the high dose yielded similar findings to the original study with an increased Q̇, 
while further providing evidence of increased PmvO2. Recently the effect on Q̇ was investigated 
in human subjects (19, 62), but no change in brachial artery blood flow (Q̇BA) was found in 
healthy, young men and women during moderate intensity single handed handgrip exercise, 
consistent with the findings of low dose BR in rats. 
 O2 cost during exercise 
 It has been demonstrated that BR supplementation will reduce V̇O2 in a manner not 
unlike that shown by Larsen et al., (72). Bailey and colleagues (7) were the first to show this. 
These authors showed that BR supplementation reduced the V̇O2 during moderate intensity 
exercise, but this reduction was not apparent when exercise was performed in the severe domain. 
Subsequent studies utilizing BR supplementation have yielded mixed results across a variety of 
exercise modalities, with some showing modest reductions in V̇O2 (4, 70, 100, 105), and others 
no change (13, 21, 59, 60) after supplementation. Initial evidence appeared to suggest that BR 
had the greatest effect during moderate intensity exercise and/or in untrained subjects (4, 7, 105), 
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but again this finding has not been universally observed (69, 70, 102). NIRS-derived variables 
have been measured concurrently with V̇O2 in two studies to date (7, 13). Deoxy-[Hb + Mb], 
which represents the microvascular matching of V̇O2 to Q̇, paralleled the change in V̇O2 when it 
occurred (7, 13). 
 The findings covered in this review highlight the value of BR supplementation as 
both an ergogenic and therapeutic aid. However, the studies performed over the last decade have 
shown variance in outcomes, which highlights the need for a greater understanding of the 
underlying physiological effects of BR. This supplement can be prescribed with greater efficacy 
once the specific physiological, environmental, and exercise conditions that provoke the greatest 
effect of the supplement are better understood. 
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Chapter 3 - Methods 
 Subjects 
Seven healthy, recreationally active men volunteered for this investigation (mean ± SD: 
age: 25 ± 3 yrs; height: 179 ± 4 cm; body mass: 82 ± 9 kg). All experimental procedures in the 
present study were approved by the Institutional Review Board at Kansas State University and 
conformed to the standards set forth by the Declaration of Helsinki. Prior to participation in the 
study, all subjects were informed of the protocol, any possible health risks, as well as the 
probable benefits of the study. All subjects provided written informed consent to participate and 
completed a medical health history questionnaire to ensure absence of any known cardiovascular 
or metabolic diseases which would preclude them from the study.  
 Experimental Protocol 
 All testing sessions were performed on a custom-built, two-handed handgrip ergometer 
previously described by Broxterman et al. (15). Briefly, the subjects were seated in an upright 
position at arm’s length from the ergometer with the hands at heart level and directly in front of 
their torso. All sessions were performed utilizing a 50% duty-cycle (1.5 s contraction, 1.5 s 
relaxation) that was maintained via audio cues. All subjects were familiarized with the exercise, 
audio cues, and duty-cycle prior to the first testing session. During the first visit, subjects 
performed an incremental test for the determination of peak power (Ppeak) starting at 1 Watt (W) 
and increasing at 0.5 W·min
-1
. The test was performed until volitional exhaustion or after three 
consecutive contraction cycles in which the subject was unable to maintain the correct tempo or 
complete full contractions. Ppeak was recorded as the highest power obtained in which the 
subjects completed at least 30 s of the stage.  
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The four subsequent visits were randomly assigned to 40 or 85 %Ppeak and performed for 
10 min or until exhaustion, respectively. All testing sessions were separated by at least 48 h and 
subjects were asked to abstain from vigorous activity, food, and caffeine prior to testing for 12, 
3, and 2 h, respectively. Upon arrival to the laboratory, the subjects sat quietly for 10 min, after 
which resting blood pressure measurements and subsequent plasma samples were obtained.  All 
exercise tests were performed at approximately the same time of day (± 1.5 h for each subject) 
between 1100 and 1500 hours. 
 Supplementation 
 The four exercise testing sessions were randomly assigned to either BR or placebo (PL) 
supplementation conditions, creating a randomized, double-blind, crossover study design. In 
each condition, the subjects consumed BR concentrate (2 x 70 ml providing ~13 mmol NO3
-
) or 
nitrate-depleted beetroot juice concentrate PL (2 x 70 ml providing ~0.006 mmol NO3
-
; both 
from Beet it, James White Drinks, Ipswich, UK). Subjects consumed the shots ~2.5 h before 
testing began to allow for maximal expression of plasma NO3
- 
concentrations ([NO3
-
]) (101). 
During the study, subjects were asked to abstain from using mouthwash (44) and toothpaste or 
chewing gum that contained triclosan, as these products serve to reduce the oral bacteria needed 
to facilitate the conversion of NO3
-
 to NO2
-
. Each exercise testing session was separated from the 
others by at least 48 h to allow plasma [NO3
-
] adequate time to return to pre-supplementation 
concentrations (105). Subjects were asked to maintain their normal diet with the exception of 
limiting foods high in NO3
-
, such as spinach and arugula (74). No subjects reported taking any 
multivitamins or anti-oxidant supplements. 
19 
 Measurements 
 Venous blood samples (5-6 ml) were separated into 1.5 ml Eppendorf tubes containing 5 
μl heparin (concentration 1000U/ml) and centrifuged at 3250 rpm at 4 °C for 5 min. Plasma 
samples were removed into separate tubes, flash frozen in liquid nitrogen, and stored at -80 °C 
until later analysis.  
 The measurements of plasma NO3
-
 and NO2
-
 were performed within 30 min of thawing 
via chemiluminescence with a NO analyzer (NOA 280i, Sievers Instruments, Boulder, CO, 
USA). In order to obtain plasma NO2
-
 levels and to avoid potential reduction of NO3
-
, potassium 
iodide in acetic acid was used as a reductant. This reductant has the ability to reduce NO2
-
 to NO 
but is incapable of reducing higher oxides of nitrogen (i.e., NO3
-
), thus increasing the specificity 
for NO2
-
. Plasma NO3
-
 concentrations were obtained using the same apparatus with the stronger 
reductant vanadium chloride in hydrochloric acid at a temperature of 95 °C. This stronger 
reductant reduces the sum of all nitrogen oxides with an oxidation state of +2 or higher, which is 
predominately NO3
-
 (μM), but also includes both NO2
-
 (nM) and nitrosothiols (nM). 
Blood pressure was measured in the left ankle using an automated patient monitor (S/5 
Light Monitor type F-LM1-03, Datex-Ohmeda General Electric, Findland) which makes use of 
the oscillometric technique. To increase accuracy, the machine utilizes a 3-lead ECG to monitor 
heart rate (HR). During the measurement, subjects were asked remain still and allow their leg to 
relax. A correction factor (pressure = measured pressure – (distance between the heart and ankle 
in meters x 76 mm Hg) was used to adjust for the increased hydrostatic pressure present between 
the ankle and heart (42). Pilot work performed in our lab validated the correction factor with 
measurements taken from the ankle and arm at heart level while the subjects sat at the ergometer. 
The raw blood velocity profiles were measured in the right brachial artery using Doppler 
ultrasound (Vivid 3, GE Medical Systems, Milwaukee, WI, USA) operating in pulse wave mode 
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at a Doppler frequency of 4.0 MHz with a phased linear array transducer probe operating at an 
imaging frequency of 6.7 MHz, and were stored for post-hoc analysis. For all testing sessions the 
Doppler gate was set to the full width of the brachial artery to ensure complete insonation and all 
Doppler velocity measurements were corrected for the angle of insonation, which was adjusted 
to be less than 60°. Measurements were made at least 3 cm above the antecubital fossa to avoid 
bifurcation of the brachial artery. Brachial artery diameters were measured in the transverse axis 
using two-dimensional sonography. 
 Muscle and microvascular oxygenation status were measured noninvasively using a 
frequency-domain multi-distance near infrared spectroscopy (NIRS) system (OxiplexTS, ISS, 
Champaign, IL, USA) positioned over the belly of the left flexor digitorum superficialis (FDS). 
Details of this technique have been described previously (15, 17). Briefly, this device consists of 
one detector fiber bundle and eight light-emitting diodes (LED) operating at wavelengths of 690 
and 830 nm (four LEDs per wavelength). The LED-detector fiber bundle separation distances are 
2.0, 2.5, 3.0, and 3.5 cm. This NIRS device measures and incorporates the reduced scattering 
coefficient (μs’), measured dynamically, to provide absolute concentrations (μM) for deoxy-[Hb 
+ Mb] and total-[Hb + Mb]. The NIRS probe was calibrated prior to each test according to the 
manufacturer’s specifications. The belly of the FDS of the left arm was identified using palpation 
and EMG. The NIRS probe was secured along the belly of the FDS and was wrapped with an 
elastic bandage to prevent shifting of the probe. The placement of the NIRS probe was marked 
with permanent ink for reproducible positioning throughout the study. The NIRS data were 
collected at 50 Hz and stored for post-hoc analysis.  
The V̇O2 (ml O2·min
-1
) of the FDS was estimated for each minute of exercise using the 
technique described previously (15), which integrates deoxy-[Hb + Mb] and Q̇BA. It was 
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assumed that the deoxy-[Hb + Mb] signal reflects exclusively deoxy-[Hb] [we acknowledge that 
the signal contains deoxy-[Mb] as well (28)] and that the entire signal arises only from the 
muscle (i.e., not from any interposing adipose or skin tissue).  With these assumptions the deoxy-
[Hb] may be converted into an estimated V̇O2.  The deoxy-[Hb] values are in units of μmole 
heme/l tissue, where the tissue is assumed to be muscle.  These deoxy-[Hb] units can be 
converted into μmole heme/l blood using the conversion 1.36% capillary blood volume/muscle 
volume [derived from 400 cap/mm
2, 28.3 μm2 CSA, and a coefficient of 1.2 correcting for 
tortuosity and branching of the capillaries (85)].  These units can then be converted into mole 
O2/l blood assuming 1 mole O2/mole heme and further to l O2/l blood using the conversion 22.4 l 
O2/mole O2.  V̇O2 values in l O2/min may then be obtained by multiplying this value by the 
measured Q̇BA values. 
 Data analysis 
Mean blood velocity (V̇mean; cm·s
-1
) was defined as the time-averaged mean velocity over 
each 3 s contraction cycle. Q̇BA (ml·min
-1
) was calculated using the product of V̇mean and vessel 
cross-sectional area (CSA = πr2). CSA (cm2) was calculated each minute of exercise using 
brachial artery diameters measured at the beginning of each minute. The Q̇BA data were analyzed 
using three consecutive contraction cycles (i.e., 9 s) for rest and at the end of each minute of 
exercise. The NIRS data were analyzed using 1 s mean values that were converted to 30 s mean 
bins for resting values and 9 s time-binned mean values at the end of each minute of exercise and 
at exhaustion. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured 
at least three times at rest and once every 2 min during exercise and were then used to calculate 
MAP. Vascular conductance (VC) (ml·min
-1
·(100 mmHg)
-1
) was calculated using the quotient of 
Q̇BA/MAP, multiplied by 100.  
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Kinetics analyses were conducted for the Q̇BA and V̇O2 data during 85% Ppeak using 6 s 
time-binned mean values over the initial 120 s of exercise and 9 s time-binned mean values at 
180 and 240 s with a mono-exponential model:  
y(t) = y(b) + A(1 – e –(t – TD)/τ) 
where y(t) is the Q̇BA or V̇O2 at any point in time, y(b) is the appropriate baseline before the onset 
of exercise, A is the peak amplitude of the response, TD is the time delay proceeding the increase 
in, and τ is the time constant. 
 Statistical analysis 
 All curve fitting and statistical analyses were performed using a commercially 
available software package (SigmaPlot, Systat Software, San Jose, CA, USA). Differences in 
resting values, kinetic parameters, and Tlim were analyzed using Student’s paired t-tests. 
Differences within condition (i.e., 40% BR and 85% BR) at rest were compared and if no 
differences were found, these values were averaged to represent the mean resting value for that 
condition. All exercising values were analyzed using two-way ANOVAs with repeated measures 
(condition x time) using Tukey’s post hoc tests when main effects were detected. Differences 
were considered significant when p ≤ 0.05. Data are presented as mean ± standard deviation 
unless otherwise noted. 
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Chapter 4 - Results 
 Plasma [NO3
-
] & [NO2
-
] and resting blood pressure 
 Plasma [NO3
-
] was elevated 26-fold over PL after acute BR supplementation (795 ± 76 vs 
29 ± 5 μM, p < 0.001). All subjects demonstrated an elevated plasma [NO2
-
] after acute BR 
supplementation (469 ± 139 vs 69 ± 17 nM, p < 0.001, Fig. 1), resulting in a 5.8-fold increase 
over PL. Resting blood pressure values are presented in Table 1. SBP, DBP, and MAP were 
significantly reduced after acute BR supplementation by 8.4%, 7.7%, and 8.7%, respectively.  
 40 %Ppeak exercise  
 The mean power for 40 %Ppeak was 2.3 ± 0.3 W. All subjects were able to sustain 10 min 
of exercise at 40 %Ppeak in both conditions. Q̇BA increased rapidly from exercise onset in both 
conditions before approaching a steady-state of approximately 285 ml·min
-1
 by 240 s. Q̇BA was 
not significantly different after BR supplementation at rest or at any time during exercise 
compared to PL (Fig. 2). There was no main effect for BR on MAP during exercise compared to 
PL (p = 0.102, Fig. 3), although MAP was lowered by 4.6 mmHg on average throughout 
exercise. There was no effect of BR on VC (p = 0.323, Fig. 3). 
 Deoxy-[Hb + Mb] increased following exercise onset in both conditions, with PL 
showing an overshoot that quickly transitioned to a lower steady-state by 120 s (Fig. 4). The 
overshoot with BR was significantly greater and extended through 120 s (47.4 ± 13.8 vs 42.1 ± 
12.0 μM, p = 0.014) and 180 s (46.3 ± 14.1 vs 42.2 ± 13.5 μM, p = 0.049). However, end 
exercise deoxy-[Hb + Mb] was not different between BR and PL (43.3 ± 9.6 vs 42.4 ± 15.1 μM, 
p = 0.649). Total-[Hb + Mb] was not significantly different after BR supplementation. The 
estimated V̇O2 was not significantly different between BR and PL at any min during exercise or 
at the end of exercise (21.8 ± 12.2 vs 22.4 ± 14.2 ml O2·min
-1
, Fig. 6). 
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 85 %Ppeak exercise 
 The mean power for 85 %Ppeak was 4.8 ± 0.5 W. BR had no significant effect on Tlim 
compared to PL (342 ± 83 vs 382 ± 138 s, p = 0.382, Fig. 5). Q̇BA was not significantly different 
at rest or any time during exercise after BR supplementation. Q̇BA increased at exercise onset and 
attained end exercise values that were not significantly different between BR and PL (369 ± 155 
vs 391 ± 135 ml·min
-1
, p = 0.341, Fig. 2). 
 Deoxy-[Hb + Mb] increased at exercise onset in both conditions, with BR significantly 
elevated over PL for all common time points preceding end exercise (60 – 240 s, p < 0.05). At 
end exercise, BR and PL were not statistically different (54.4 ± 19.7 vs 49.1 ± 14.5 μM, p = 0.07, 
Fig. 4). Total-[Hb + Mb] was not significantly different after BR supplementation, both 
conditions showing a progressive increase toward the end exercise values.  There was no 
difference for estimated end-exercise V̇O2 after BR supplementation (31.0 ± 10.4 vs 30.7 ± 10.9 
ml O2·min
-1
, Fig. 6). 
 Kinetics analyses 
 The results of the kinetics analyses are presented in Table 2. Kinetics analysis of 
V̇O2 was conducted with 5 subjects, as two of the subjects exhibited a response to the onset of 
exercise (in opposite supplementations) which was atypical and determined to be an outlier (≥ 4 
SDs from the mean). BR had no significant effect on Amp, τ, or TD for Q̇BA or V̇O2 following 
exercise onset. Although no significant differences were detected for the Amp (p = 0.06) or τ (p 
= 0.196) of the V̇O2 response, large effect sizes of 1.14 and 0.7, respectively, were found. 
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Figure 1. Resting nitrite concentrations 
Plasma nitrite concentration ([NO2
-
]) for each individual subject (solid lines) and group mean 
(dashed line). Error bars represent SE. *, significantly different from placebo (p < 0.001). 
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Figure 2. Brachial artery blood flow during exercise 
Top: Mean brachial artery blood flow (Q̇BA) at the end of each minute of 40 %Ppeak exercise. 
Below: Mean Q̇BA at the end of each minute of 85 %Ppeak exercise and the limit of exercise 
tolerance (Tlim). In both graphs, filled circles represent placebo and open circles represent 
beetroot supplementation. Error bars represent SE. 
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Figure 3. Mean blood pressure and vascular conductance responses to 40 %Ppeak exercise 
Top: Mean arterial pressure (MAP) taken every 120 s during exercise. Below: Vascular 
conductance (VC) calculated as the product of brachial artery blood flow and MAP every 120 s 
during exercise. In both graphs, filled circles represent placebo and open circles represent 
beetroot supplementation. Error bars represent SE. *, significantly different from placebo (p < 
0.05). The data point for 600 s represents the mean value in the absence of one different 
individual in each condition (i.e., a mismatched n = 6).  
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Figure 4. NIRS-derived muscle and microvascular oxygenation responses during exercise 
A: 40 %Ppeak exercise Top: Mean deoxygenated-[hemoglobin + myoglobin] (deoxy-[Hb + Mb]) 
at the end of each minute of exercise. Below: Mean total-[hemoglobin + myoglobin] (total-[Hb + 
Mb]) at the end of each minute of exercise. B: 85 %Ppeak exercise Top: Mean deoxy-[Hb + Mb] 
at the end of each minute of exercise and at the limit of exercise tolerance (Tlim). Below: Mean 
total-[Hb + Mb] at the end of each minute of exercise and at Tlim. In all graphs, filled circles 
represent placebo and open circles represent beetroot supplementation. Error bars represent SE. 
*, significantly different from placebo (p < 0.05). 
29 
 
Figure 5. Effect of supplementation on tolerance to exercise 
Individual (solid lines) and mean (dashed line) tolerance to exercise (Tlim) responses under both 
supplementations during 85 %Ppeak exercise. Error bars represent SE. 
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Figure 6. Estimated V̇O2 during exercise 
Top: Mean estimated V̇O2 at the end of each minute of 40 %Ppeak exercise. Below: Mean 
estimated V̇O2 at the end of each minute of 85 %Ppeak exercise and at the limit of exercise 
tolerance (Tlim). Error bars represent SE. 
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Table 1. Resting blood pressure 
  Placebo Beetroot 
SBP (mmHg) 133 ± 7 122 ± 8 ǂ 
DBP (mmHg)   64 ± 8    59 ± 7 * 
MAP (mmHg)   87 ± 7   79 ± 6 ǂ 
SBP, DBP, and MAP denote systolic blood pressure, diastolic blood pressure, and mean arterial pressure, 
respectively. Values are expressed as mean ± SD   
ǂ, significantly different from placebo (p < 0.01)  *, significantly different from placebo (p < 0.05) 
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Table 2. Kinetics parameters 
Q̇BA  Placebo Beetroot 
Amp (ml·min
-1
)   258 ± 53 278 ± 81 
τ (s)    46 ± 43    43 ± 26 
TD (s)    4 ± 5   3 ± 4 
V̇O2   
Amp (ml O2·min
-1
)   21 ± 9   29 ± 14 
τ (s)     38 ± 14 31 ± 8 
TD (s)     1 ± 2   4 ± 4 
Amp, τ, and TD denote the primary amplitude, time constant, and time delay, respectively. Values are 
expressed as mean ± SD   
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Chapter 5 - Discussion 
The present study investigated the effects of acute BR supplementation on conduit artery 
Q̇ concurrently with muscle and microvascular oxygenation characteristics during moderate and 
severe intensity handgrip exercise. The acute dosage utilized (~13 mmol NO3
-
), elevated plasma 
[NO2
-
] more than 5-fold higher than that seen with placebo and resulted in significant reductions 
in blood pressure at rest. In agreement with our first hypothesis, and previous findings (19, 62), 
BR had no significant effect on Q̇BA at rest or any time point during moderate or severe intensity 
handgrip exercise compared to PL. The primary novel finding of the present study, in contrast to 
our second hypothesis, was that the V̇O2 was not significantly different after BR during moderate 
or severe intensity handgrip exercise. Additionally, BR had no significant effect on Tlim when 
exercise was performed in the severe intensity domain.  
 Protocol advantages 
 Handgrip exercise provides several advantages over commonly used whole body exercise 
modes (i.e., cycling and running) considering the measurements that can be made. The similar 
fiber type composition of the FDS and vastus lateralis (VL) (40, 55, 94) allows translation of 
metabolic findings between the two. With whole body exercise, measurement of Q̇ (via 
ultrasound) through the conduit (femoral) artery is obstructed due to the dynamic movement of 
the legs and requires the use of invasive techniques such as thermodilution. Conversely, Q̇ can be 
noninvasively and accurately measured from rest to maximal effort during handgrip exercise. 
Similarly, the use of NIRS to measure the oxygenation of the VL and other leg muscles is 
complicated by the presence of a sizable layer of adipose tissue (38) which thus limits 
penetration of the light into only the superficial portions of the muscles. To further complicate 
the interpretation of these signals in the thigh musculature, a distinct spatial heterogeneity of 
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deoxy-[Hb + Mb] has been observed during cycling exercise (67). Handgrip exercise allows for 
the use of NIRS on the active muscle with a reduced relative contamination of the adiposity to 
the overall signal and for the interrogation of the entire active muscle, both of which enable a 
more comprehensive description of the underlying physiology. 
 Effect on plasma [NO2
-
] and blood pressure 
 An acute dose of BR resulted in a 581% increase in plasma [NO2
-
] 2.5 hours after 
consumption, supporting the accumulating evidence that both acute and chronic BR 
supplementation can significantly increase the plasma concentrations of NO3
-
 and NO2
-
 in both 
healthy and patient populations (61, 100, 101, 105, 106) and animal preparations (36, 37). Often, 
although not ubiquitously, the increase in plasma [NO2
-
] is accompanied by a significant 
reduction in SBP, DBP, and/or MAP (for review see (51)). The present study showed an 8% 
decrease in all three variables at rest and a non-significant decrease in MAP during exercise, 
reminiscent of the significant reduction measured in exercising rats (37). Although the effects 
during exercise may have been underpowered in the present study, the effect of BR 
supplementation on blood pressure regulation suggests that BR may be valuable to acutely and 
chronically (at least 15 days (100)) control moderate hypertension. 
 Effect on control of blood flow 
 The discovery of NO and its critical importance as a signaling molecule in the 
cardiovascular system, coupled with the demonstration that dietary NO3
- 
is reduced to NO2
- 
and 
then NO (75), inspired the hypothesis that BR would increase Q̇, particularly in hypoxic and 
acidic tissues such as contracting muscle. Before this was directly tested, Cosby and colleagues 
(26) performed a seminal study that investigated the effect of a direct injection of inorganic NO2
- 
into the forearm vasculature of man, and found the injection increased Q̇BA during both rest and 
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exercise. Later studies investigated the effect of BR on exercise performance and muscle 
oxygenation utilizing NIRS and found deoxy-[Hb + Mb] to be reduced, which was attributed to 
increased blood volume associated with vasodilation (7, 61). Subsequently, Ferguson and 
colleagues (36, 37) discovered that BR supplementation increased hindlimb Q̇, and presumably 
microvascular red blood cell content (63), in a fiber type specific manner in rats. 
 To date, the previous studies (19, 62) and the present investigation that directly measured 
Q̇ in humans, have be unable to replicate the findings of Ferguson et al. (36, 37) or Cosby et al. 
(26) after BR supplementation. It must be noted that the dose of BR given to the rats was much 
greater than that typically administered to humans and was dispersed chronically over 5 days. 
Further, the largest effect was seen in muscles composed of a high percentage of type IIb and IIx 
fibers. The dose administered was designed to account for the 7-fold higher resting V̇O2 that rats 
exhibit compared to humans (80). To match this dosing, the subjects in the present study would 
need to consume approximately 13 servings (~85 mmol NO3
-
) of the supplement utilized. This 
may be excessive because the plasma [NO3
-
] in the present investigation exceeded that of the 
high dose rats by 500% (36). The plasma [NO2
-
] was 22% lower than that in the high dose rats, 
suggesting possible differences in the conversion process between humans and rats, differences 
in the site of intravascular storage of NO2
-
 (30), or an effect emerging as a consequence of the 
chronic supplementation. Although human plasma [NO2
-
] appears steady over 5 days of 
supplementation (100), there is evidence for intracellular changes to protein expression and 
mitochondria with long-term NO2
-
 exposure (16, 23). How these alterations might function to 
increase Q̇ during exercise is currently unclear. 
 Although data are sparse, the fiber type composition of the human forearm flexor muscles 
is closely matched to the composition of the VL with a distribution of 50-60% type II fibers (40, 
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55, 94). This distribution is quite disparate from the hindlimb of the rat, which is composed of 
>90% mixed type II fibers (3). Nevertheless, a recent study found that BR increased peak cardiac 
output and V̇O2 in CHF patients during a supine maximal incremental exercise test (106). 
However, that study was not designed to resolve the spatial distribution of the ~10% increase in 
cardiac output. If BR does favorably affect VC and Q̇ to type II fibers, as suggested by Ferguson 
and colleagues (37), the increased proportion of type II fibers with ageing, CHF, and other 
diseases (43, 93) supports the notion that BR supplementation may be more effective in these 
populations. The absence of an effect during severe intensity exercise in the present study, when 
type II fibers are thought to be recruited more heavily, suggests a more complex relationship 
between plasma NO2
-
 and vascular control than presently appreciated. However, any differences 
in control of the circulation between upper and lower limbs may exacerbate the complexity of 
this relationship. 
 Effect on tissue oxygenation and estimated V̇O2  
 Larsen et al. (72) were the first to show that a dietary NO3
-
 supplement could reduce the 
V̇O2 associated with a given work rate. Subsequent studies utilizing BR supplementation have 
yielded mixed results across a variety of exercise modalities, with some showing modest 
reductions in V̇O2 (4, 7, 70, 100, 105), and others no change (13, 21, 59, 60) after 
supplementation. Initial evidence appeared to suggest that BR had the greatest effect during 
moderate intensity exercise and/or in untrained subjects (4, 7, 105), but again this finding has not 
been universally observed (69, 70, 102). NIRS-derived variables have been measured 
concurrently with V̇O2 in two studies to date (7, 13). Deoxy-[Hb + Mb], which represents the 
microvascular matching of V̇O2 to Q̇, paralleled the change in V̇O2 when it occurred (7, 13).  
37 
 Given the above, it was surprising that, in the present investigation, deoxy-[Hb + Mb] 
was elevated significantly after BR supplementation at min 2 and 3 during moderate exercise and 
throughout severe intensity exercise. Moreover, the total-[Hb + Mb] during both exercise bouts 
was not significantly impacted by BR supplementation. Changes in total-[Hb + Mb] from rest to 
exercise are thought to reflect the change in microvascular hematocrit (28), in that any change 
from rest to exercise would represent a net change in Hb concentration associated with red cells 
rather than a change in concentration of Mb, which presumably is fixed. To the best of our 
knowledge, the current study is the first to observe an increased deoxy-[Hb + Mb] after BR 
supplementation. When the increased deoxy-[Hb + Mb] is considered in relation to the 
unchanged total-[Hb + Mb] (and Q̇BA), it would suggest an increased fractional O2 extraction for 
the same work being performed. However, there was no difference between the estimated V̇O2 
after BR supplementation in the present study during exercise. It has been shown that duty-
cycles ≥ 50% mechanically constrain Q̇BA and V̇O2 during handgrip exercise (15, 99). This duty-
cycle imposed mechanical limitation may mask any effect of BR supplementation. 
 Effect on kinetics parameters 
 No differences in the absolute amplitude of Q̇BA or V̇O2 were found in the present study, 
but kinetics analyses revealed large effect sizes for the V̇O2 amplitude and time constant after BR 
supplementation. The primary amplitude of V̇O2 over the first 240 s of exercise at 85% Ppeak 
approached a significant increase, before reaching similar end exercise values. These findings are 
in agreement with the speeding of pulmonary V̇O2 kinetics shown during whole body exercise (6, 
13, 59) and the equivalent PmvO2 response discovered in rats (36). The ability to dissociate the 
effects of BR by implementing slow pedal cadence (and presumably high duty-cycle) reported 
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by Bailey and colleagues (6) may provide insight to the inconsistent findings of the efficacy of 
BR, in this regard.  
 Limitations 
 An acute bolus of BR was utilized herein, which showed similar effects on blood 
pressure regulation as seen with chronic supplementations. Chronic supplementation of BR 
augments Q̇ in rats (36, 37); however, in agreement with previous studies in young adults (19, 
62), an acute dose in humans has not yielded the same outcome. As such, future research might 
usefully employ chronic supplementation to determine if multiple days are required to observe 
this Q̇ augmentation, possibly via protein modification (16). Similarly, exercise activating a 
larger muscle mass that still allows accurate measurement of Q̇ (i.e., knee extension) would help 
to determine if the effect of BR is related in some fashion to the size of muscle mass recruited. It 
is feasible that handgrip exercise does not recruit a large enough group of muscles with a 
subsequently large enough bed of vasculature to impact upstream conduit Q̇ measurements. 
Finally, it remains to be determined if the upper and lower body control Q̇ and V̇O2 differently 
during exercise, and if differences that may exist are associated with dissimilar sensitivity to BR. 
We acknowledge that the method used to estimate V̇O2 herein utilizes several assumptions (15). 
We contend that these assumptions, held constant throughout, should not obscure an impact of 
BR on V̇O2. 
 Conclusions 
 The present study reaffirmed previous findings that an acute dose of BR is 
sufficient to lower SBP, DBP, and MAP in young adults, suggestive of its value as a method to 
control moderate hypertension and improve vascular health. However, the beneficial effects 
associated with BR supplementation during large muscle mass exercise were not seen when the 
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exercise was performed in small muscle mass handgrip exercise utilizing a 50% duty-cycle. 
These findings emphasize the limitations to the efficacy and utility of BR supplementation as it 
may have reduced effect during small muscle mass exercises. Similarly, the duty-cycle of a given 
exercise may largely attenuate any potential benefit imparted by BR supplementation as shown 
in the present study and the recent work by Bailey et al., (6). These factors, combined with the 
complex relationship between plasma NO2
-
 and vascular control, may provide insight into the 
varying exercise performance outcomes of BR supplementation. 
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